Clinical Trial Update: Controlled Crossover Study of AIONX Antimicrobial Surface for the Prevention of Healthcare-associated Infections [Phase 2]

View source ↗

Summary

Clinical trial update for a Phase 2 controlled crossover study of the AIONX antimicrobial surface to prevent healthcare-associated infections; current status is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Healthcare-associated Infection

Drugs mentioned

• AIONX Antimicrobial Surface

Snippet

Sponsor: Aionx, Inc. | Conditions: Healthcare Associated Infection | Phase 2 | Status: UNKNOWN